Cancer-specific killing by the CD suicide gene using the human telomerase reverse transcriptase promoter
文献类型：期刊论文
| 作者 | Liu, J; Zou, WG; Lang, MF; Luo, J; Sun, LY; Wang, XN; Qian, QJ; Liu, XY |
| 刊名 | INTERNATIONAL JOURNAL OF ONCOLOGY
 |
| 出版日期 | 2002 |
| 卷号 | 21期号:3页码:661-666 |
| 关键词 | hTERT promoter CD colorectal cancer gene therapy |
| 通讯作者 | Liu, XY (reprint author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China.,xyliu@server.shcnc.ac.cn |
| 英文摘要 | Human telomerase reverse transcriptase (hTERT), the catalytic subunit of the telomerase, is transcriptionally upregulated in more than 90% of tumor cells. It may be used as a tool for driving a gene to kill tumors specifically. To test this idea, luciferase reporter gene was used and the results showed that hTERT promoter could restrict the gene expression in the telomerase-positive tumor cells. A tumor-specific expression plasmid phTERT-CD was constructed, in which the E. coli cytosine deaminase (CD) gene was controlled by the hTERT promoter. A colorectal cancer cell line (LoVo) and a normal amnion cell line (WISH) were transfected by this plasmid. It was shown that the expression of the CD gene increased the sensitivity of LoVo cells to the prodrug, 5-fluorocytosine (5FC), over 800-fold, while the sensitivity of WISH cells to 5FC was increased only 6-fold. Mixed cell experiments showed a strong 'bystander effect' on CD-negative cells. Furthermore, a significant anti-tumor effect of the phTERT-CD/5FC system was observed in nude mice bearing mammalian carcinoma induced by s.c. inoculation of LoVo cells when the mice were given 250 mg/kg 5FC twice a day for 10 consecutive days. These results indicated that hTERT promoter could target the suicidal effect of CD gene to tumor cells, and therefore, may be a novel and promising targeting approach to the treatment of cancer. |
| 学科主题 | Oncology |
| 类目[WOS] | Oncology |
| 关键词[WOS] | CATALYTIC SUBUNIT HTERT ; HUMAN BONE-MARROW ; TRANSGENE EXPRESSION ; GLIOMA-CELLS ; THERAPY ; CARCINOMA ; ADENOVIRUS ; ACTIVATION ; COMPONENT ; ANTIGEN |
| 收录类别 | SCI |
| 语种 | 英语 |
| WOS记录号 | WOS:000177375100029 |
| 版本 | 出版稿 |
| 源URL | [http://202.127.25.143/handle/331003/2456]  |
| 专题 | 上海生化细胞研究所_上海生科院生化细胞研究所 |
| 推荐引用方式 GB/T 7714 | Liu, J,Zou, WG,Lang, MF,et al. Cancer-specific killing by the CD suicide gene using the human telomerase reverse transcriptase promoter[J]. INTERNATIONAL JOURNAL OF ONCOLOGY,2002,21(3):661-666. |
| APA | Liu, J.,Zou, WG.,Lang, MF.,Luo, J.,Sun, LY.,...&Liu, XY.(2002).Cancer-specific killing by the CD suicide gene using the human telomerase reverse transcriptase promoter.INTERNATIONAL JOURNAL OF ONCOLOGY,21(3),661-666. |
| MLA | Liu, J,et al."Cancer-specific killing by the CD suicide gene using the human telomerase reverse transcriptase promoter".INTERNATIONAL JOURNAL OF ONCOLOGY 21.3(2002):661-666. |
入库方式： OAI收割
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。